Insider · CIK 0001709258

Schuchart Aaron

Reports to the SEC for 2 companies · AUSTIN, TX

sec.gov

Transactions

Companies

Filings

CIK

0001709258

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−8,179 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−45K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−7,805 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−8,500 sh	—	—	0
2024-04-01	LUMOS PHARMA, INC.A Award	Chief Business Officer	AAward	+1,000 sh	$2.84	+$2,840	6,679
2024-04-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+12K sh	—	—	12,000
2024-02-01	LUMOS PHARMA, INC.F Tax Payment	Chief Business Officer	FTax Payment	−202 sh	$3.01	−$608.02	5,679
2023-02-01	LUMOS PHARMA, INC.A Award	Chief Business Officer	AAward	+1,000 sh	$3.52	+$3,520	5,485
2023-02-01	LUMOS PHARMA, INC.F Tax Payment	Chief Business Officer	FTax Payment	−104 sh	$3.52	−$366.08	5,381
2023-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+12K sh	—	—	12,000
2022-02-01	LUMOS PHARMA, INC.A Award	Chief Business Officer	AAward	+1,000 sh	$10.02	+$10K	4,037
2022-02-01	LUMOS PHARMA, INC.F Tax Payment	Chief Business Officer	FTax Payment	−52 sh	$10.02	−$521.04	3,985
2022-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+12K sh	—	—	12,000
2021-08-12	LUMOS PHARMA, INC.P Purchase	Chief Business Officer	PPurchase	+1,700 sh	$7.42	+$12.6K	3,037
2021-08-11	LUMOS PHARMA, INC.P Purchase	Chief Business Officer	PPurchase	+300 sh	$7.35	+$2,205	1,337
2021-06-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+7,805 sh	—	—	7,805
2019-02-28	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+60K sh	—	—	60,000
2018-09-27	SYRESpyre Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−100 sh	$9.55	−$955	8,400
2018-09-27	SYRESpyre Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−5,900 sh	$9.50	−$56.1K	2,500
2018-08-17	SYRESpyre Therapeutics, Inc.M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+8,500 sh	$3.50	+$29.8K	8,500
2018-08-17	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−8,500 sh	—	—	91,500
2018-02-20	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+20K sh	—	—	20,000
2017-08-22	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+10K sh	—	—	10,000
2017-06-16	SYRESpyre Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Dec 134
Schuchart Aaron0001126234-24-000114
SEC(opens sec.gov)
Apr 34
Schuchart Aaron0001126234-24-000034
SEC(opens sec.gov)
Feb 54
Schuchart Aaron0001126234-24-000013
SEC(opens sec.gov)
Feb 34
Schuchart Aaron0001126234-23-000018
SEC(opens sec.gov)
Feb 34
Schuchart Aaron0001126234-22-000012
SEC(opens sec.gov)
Aug 134
Schuchart Aaron0001126234-21-000113
SEC(opens sec.gov)
Jun 34
Schuchart Aaron0001126234-21-000088
SEC(opens sec.gov)
Mar 14
Schuchart Aaron0001567619-19-005836
SEC(opens sec.gov)

Companies

Address

C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250

AUSTIN, TX, 78746